-

BeOne Medicines Launches One Save Changes Everything, a Global Cancer Care Awareness Campaign with Soccer Legend Tim Howard

Campaign connects the preparation, precision, and grit that define great goalkeeping to the persistent scientific, clinical, and community efforts that drive progress in cancer care

Features international goalkeepers, uniting soccer’s global reach with BeOne’s commitment to patients everywhere

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today launched One Save Changes Everything, a campaign that uses soccer as a lens to recognize the scientific, clinical, and human moments that matter in cancer care. The campaign launches with goalkeeping legends, including former U.S. Men’s National Team goalkeeper Tim Howard. The initiative is backed by a $300,000 community commitment for the installation of soccer mini-pitches near cancer treatment centers with the U.S. Soccer Foundation, and BeOne colleague‑driven charitable support across the world.

‘One Save Changes Everything’ was created to recognize the researchers who pursue targets others may have overlooked, the clinicians who act under pressure, the caregivers who show up without recognition, and the patients whose resilience fuels it all.

Share

John V. Oyler, Co-Founder, Chairman, and CEO, BeOne Medicines, said:

“Just like soccer is defined by save after save, progress in cancer is built moment by moment – in the lab, in the clinic, and in the communities where patients and families face it every day. ‘One Save Changes Everything’ was created to recognize the researchers who pursue targets others may have overlooked, the clinicians who act under pressure, the caregivers who show up without recognition, and the patients whose resilience fuels it all. BeOne was built for those moments: to be ready, to move with urgency, and to make sure progress reaches patients wherever they are. That belief drives everything we do.”

A Personal Connection to Cancer

A global soccer legend, Howard’s 16 saves against Belgium in 2014 the most in international soccer history are more than a record. They are the literal expression of the One Save Changes Everything campaign’s central belief: that preparation, presence, and the refusal to yield, applied moment after moment, can change the outcome of the most consequential events.

Howard’s connection to the campaign runs deeper than the sport. When he was 11, his grandfather was diagnosed with cancer. The ordinary evenings that followed shared dinners, quiet walks, simply being present he now recognizes as some of these moments.

Former U.S. Men’s National Team goalkeeper Tim Howard said:

“The moments that matter most aren’t always the ones people see. When my grandfather was sick, what stuck with me was our family showing up for him – quietly, consistently, and when it counted. Watching them taught me that being present, prepared, and willing to act can change everything. Partnering with BeOne feels natural because that’s how they show up for patients: every day, around the world, when it counts.”

Additional international goalkeepers will be announced to support the campaign alongside Tim Howard, along with voices from the cancer community that reflect BeOne’s global footprint.

Turning Purpose into Action

True to BeOne’s belief that purpose must translate into action, One Save Changes Everything extends beyond storytelling through a partnership with the U.S. Soccer Foundation. BeOne will fund the installation of soccer mini-pitches, creating spaces for movement, connection, and moments of normalcy for families affected by cancer.

Ed Foster-Simeon, President & CEO, U.S. Soccer Foundation said:

“Soccer has a unique ability to bring joy and connection in the most difficult moments. Placing mini-pitches near cancer centers creates permanent, accessible spaces for the families who need them most. We’re proud to partner with BeOne to create meaningful places for families to play.”

BeOne Colleagues Join One Save Changes Everything

BeOne’s more than 12,000 colleagues spanning six continents are the engine behind the donation commitment. For every hour an employee volunteers to support their community during the campaign period, BeOne will convert those hours into charitable dollars toward the $300,000 total to support the U.S. Soccer Foundation and other nonprofit organizations across the world.

One Save Changes Everything launches around the world today. Learn more at BeOneSave.com.

About BeOne Medicines

BeOne Medicines is a global oncology company that is discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The Company has a growing global team spanning six continents who are driven by scientific excellence and exceptional speed to reach more patients than ever before.

To learn more about BeOne, please visit www.beonemedicines.com and follow us on LinkedIn, X, Facebook, and Instagram.

About Tim Howard

Tim Howard is one of the most accomplished goalkeepers in U.S. soccer history. He represented the U.S. Men’s National Team from 2002 to 2017 and set the FIFA World Cup record for most saves in a single match with 16 saves against Belgium in 2014 a record that still stands. Howard played professionally for Manchester United, Everton, and the Colorado Rapids, among other clubs, over a career spanning more than two decades. He is currently a broadcaster and analyst and serves as the U.S. campaign partner for One Save Changes Everything.

To access BeOne media resources, please visit our Newsroom.

Contacts

Investor Contact
Liza Heapes
+1 857-302-5663
ir@beonemed.com

Media Contact
Kyle Blankenship
+ 1 667-351-5176
media@beonemed.com

BeOne Medicines Ltd.

NASDAQ:ONC
Details
Headquarters: San Carlos, CA & Basel, Switzerland, California
CEO: John V. Oyler
Employees: 11,000+
Organization: PUB
Revenues: $3.8B USD (2024)

$Cashtags

Contacts

Investor Contact
Liza Heapes
+1 857-302-5663
ir@beonemed.com

Media Contact
Kyle Blankenship
+ 1 667-351-5176
media@beonemed.com

Social Media Profiles
More News From BeOne Medicines Ltd.

BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the Phase 3 MANGROVE study (BGB-3111-306; NCT04002297) evaluating foundational BTK inhibitor BRUKINSA® (zanubrutinib) plus rituximab versus bendamustine plus rituximab (BR) in adult patients with previously untreated mantle cell lymphoma (MCL). MANGROVE is the first Phase 3, global, randomized trial to evaluate a BTK inhibito...

BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from its foundational hematology franchise at the 2026 European Hematology Association (EHA) Congress in Stockholm. Updated results from tacabrutideg (BGB-16673), a potential best-in-class Bruton’s tyrosine kinase (BTK) degrader, demonstrated durable responses in pretreated relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic...

BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 dataset in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) aged 80 and older, showing sustained benefit with BRUKINSA after nearly 6.5 years of follow-up, reinforcing its role as the foundational BTK inhibitor. BRUKINSA is the only BTK inhibitor to demonstrate superior efficacy vs. ibr...
Back to Newsroom